Related Experiment Video
Updated: Mar 22, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Control of glioblastoma tumorigenesis by feed-forward cytokine signaling
Arezu Jahani-Asl1,2,3,4,5, Hang Yin3,6,7,8, Vahab D Soleimani5,9
1Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
EGFRvIII-STAT3 signaling is important in glioblastoma pathogenesis. Here, we identified the cytokine receptor OSMR as a direct target gene of the transcription factor STAT3 in mouse astrocytes and human brain tumor stem cells (BTSCs). We found that OSMR functioned as an essential co-receptor for EGFRvIII. OSMR formed a physical complex with EGFRvIII, and depletion of OSMR impaired EGFRvIII-STAT3 signaling. Conversely, pharmacological inhibition of EGFRvIII phosphorylation inhibited the EGFRvIII-OSMR interaction and activation of STAT3. EGFRvIII-OSMR signaling in tumors operated constitutively, whereas EGFR-OSMR signaling in nontumor cells was synergistically activated by the ligands EGF and OSM. Finally, knockdown of OSMR strongly suppressed cell proliferation and tumor growth of mouse glioblastoma cells and human BTSC xenografts in mice, and prolonged the lifespan of these mice. Our findings identify OSMR as a critical regulator of glioblastoma tumor growth that orchestrates a feed-forward signaling mechanism with EGFRvIII and STAT3 to drive tumorigenesis.
Insights
The cytokine receptor OSMR is a key co-receptor for EGFRvIII in glioblastoma. Targeting OSMR significantly suppressed tumor growth and improved survival in glioblastoma models.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Epidermal Growth Factor Receptor variant III (EGFRvIII) and Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathways are crucial in glioblastoma (GBM) development.
- Identifying novel molecular targets is essential for effective GBM treatment strategies.
Purpose of the Study:
- To investigate the role of the cytokine receptor OSMR in EGFRvIII-driven glioblastoma.
- To elucidate the interaction between OSMR, EGFRvIII, and STAT3 signaling in tumorigenesis.
Main Methods:
- Identified OSMR as a direct STAT3 target gene in mouse astrocytes and human brain tumor stem cells (BTSCs).
- Investigated the physical interaction between OSMR and EGFRvIII using co-immunoprecipitation assays.
- Assessed the impact of OSMR depletion and EGFRvIII inhibition on signaling pathways and tumor growth in vitro and in vivo xenograft models.
Main Results:
- OSMR acts as an essential co-receptor for EGFRvIII, forming a complex that is critical for EGFRvIII-STAT3 signaling.
- Depletion of OSMR or inhibition of EGFRvIII phosphorylation disrupted this signaling axis.
- OSMR knockdown significantly suppressed glioblastoma cell proliferation and tumor growth in vivo, prolonging mouse survival.
Conclusions:
- OSMR is a critical regulator of glioblastoma tumor growth, functioning in a feed-forward loop with EGFRvIII and STAT3.
- Targeting the OSMR-EGFRvIII interaction presents a potential therapeutic strategy for glioblastoma.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
09:23Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...